Meeting
2022 ASCO Annual Meeting
Clinicopathological characteristics of high-risk multiple myeloma in Hispanic versus non-Hispanic patients in central California.
Authors
Andrew Hwang
University of California-San Francisco, Fresno, CA
Andrew Hwang , Jason Doornenbal , Daniel Park , Inderpreet Bal , Mohammed SANI Bukari , Yueqi Yan , Haifaa Abdulhaq
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies
Sub Track
Multiple Myeloma
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 8056)
DOI
10.1200/JCO.2022.40.16_suppl.8056
Abstract #
8056
Poster Bd #
479
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Survival by race and ethnicity among insured patients with early-onset colorectal cancer.
First Author: Jeffrey Lee
Poster
2023 ASCO Annual Meeting
A nationwide population based primary CNS lymphoma (PCNSL) analysis: Do Hispanics have better outcomes?
First Author: Ysaith Orellana
Poster
2023 ASCO Genitourinary Cancers Symposium
Trends and outcomes in localized renal cell carcinoma with sarcomatoid dedifferentiation: Analysis of the National Cancer Database.
First Author: Luke Wang
Poster
2022 ASCO Annual Meeting
Circulating tumor DNA analysis and association with relapse in patients with primary refractory multiple myeloma receiving secondary salvage therapy.
First Author: Sridurga Mithraprabhu